BI and Lupin will together develop and commercialise a new drug called MEK inhibitor that will target specific cancer cells and potentially treat patients of skin and stomach cancer.
Pretomanid is the third TB drug to have been approved by the USFDA in the last 40 years.
Eywa Pharma, based in Chennai and with offices in New Jersey, is the new pharma kid on the block that is entering the US market.
Naresh Sharma joined the CDSCO in November 2006, from Dabur Research Foundation. His past work experiences have involved stints with Cadila Healthcare, JK Pharmaceuticals among others.
Dr. Naresh Sharma, Deputy Drug Controller of the Central Drugs Standard Control Organisation has been suspended with immediate effect.
Pretomanid, a new chemical entity, was under development since 2002 by the TB Alliance.
'This collaboration with CSIRIICT for developing new drugs is part of our broader strategy for enhancing our global specialty pipeline.'
This collaboration with CSIR-IICT for developing new drugs is part of our broader strategy for enhancing our global specialty pipeline.
Sun Pharma reported total revenue from operations at Rs 8,259 crore, or 16 per cent higher.
The study looked at the disease through ancient Hindu Vedic scriptures to the colonial time and found that the disease dates back to 17th century in India.
- No blogs yet have been written by the author, we’re sure the author will contribute one soon